Skip to Main Content

Paper Details

G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancer.
Nat Commun
15
2021
Author NameAffiliation
Joanna CyrtaWeill Medical College of Cornell University
Elai Davicioni
Andrea SbonerWeill Medical College of Cornell University
Andrea SbonerEnglander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian Hospital
Andrea SbonerHRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College
Andrea SbonerSandra and Edward Meyer Cancer Center
Andrea SbonerWeill Medical College of Cornell University
Andrea SbonerSandra and Edward Meyer Cancer Center
Andrea SbonerHRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College
Andrea SbonerEnglander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian Hospital
Brian D RobinsonWeill Medical College of Cornell University
Brian D RobinsonEnglander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian Hospital
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Arul M ChinnaiyanMichigan Center for Translational Pathology, University of Michigan ann arbor
Mark A RubinWeill Medical College of Cornell University
Mark A RubinUniversity of Bern
Mark A RubinEnglander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian Hospital
Mark A Rubin
Mark A RubinWeill Medical College of Cornell University
Mark A Rubin
Mark A RubinEnglander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian Hospital
Mark A RubinUniversity of Bern
Christopher E BarbieriSandra and Edward Meyer Cancer Center
Christopher E Barbieri
Christopher E BarbieriEnglander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian Hospital
Christopher E BarbieriSandra and Edward Meyer Cancer Center
Christopher E Barbieri
Christopher E BarbieriEnglander Institute for Precision Medicine of Weill Cornell Medicine and New York-Presbyterian Hospital
  • 1 - 28

Datasets